Make us your home page
Instagram

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

USF researchers get closer to a cure while studying why arthritis prevents Alzheimer's

It has been known for some years that people who suffer from rheumatoid arthritis are less likely to develop Alzheimer's disease.

But now, researchers at the University of South Florida think they know why, and their findings could pave the way for a treatment for the disease.

The researchers found that a protein released into the bloodstream of people with rheumatoid arthritis provided protection against Alzheimer's in mice.

Their study appears online today in the Journal of Alzheimer's Disease.

One of the next steps could be testing the protein, known as GM-CSF, on humans. Huntington Potter, the principal investigator, noted that the man-made form of GM-CSF, known as Leukine, is already approved by the FDA to treat certain cancer patients who need to generate more immune cells.

"Our study, along with the drug's track record for safety, suggests Leukine should be tested in humans as a potential treatment for Alzheimer's disease," said Potter, a professor of molecular medicine at USF Health Byrd Alzheimer's Institute and director of the Florida Alzheimer's Disease Research Center.

People with rheumatoid arthritis — a disease that leads to inflammation of the joints and surrounding tissues — are less likely to develop Alzheimer's. It had been assumed that the non-steroidal anti-inflammatory drugs they were taking helped prevent the onset and progression of Alzheimer's. But recent clinical trials proved this was not the case.

So, USF researchers then looked at other explanations. They analyzed three growth factors of rheumatoid arthritis in mice that have been bred to develop Alzheimer's symptoms, and identified the protein GM-CSF as the most promising for protection against Alzheimer's. A 20-day study confirmed that the mice treated with GM-CSF performed better on tests measuring memory and learning than mice that were given a placebo. In fact, the memories in the treated mice were similar to normal-aged mice without dementia.

"We were pretty amazed that the treatment completely reversed cognitive impairment in 20 days," Tim Boyd, one of the lead authors of the study, said in a news release.

But success in mice doesn't necessarily mean the treatment will be beneficial to humans. Researchers have alleviated Alzheimer's-like symptoms in mice several times over, only to learn that the same treatment did not work in humans.

"It's essential people keep in mind that mice are not people," said Bill Thies, chief medical and scientific officer with the national Alzheimer's Association.

"Mice stay in their cages, eat their mice chow, and are of a very consistent genetic background," Thies said, while humans are much more complicated.

But at the same time, Thies said animal testing is essential. "It gives us the possibilities we can examine in humans."

Potter says there's reason for "cautious optimism" about the latest finding. He says it's the combination of knowing that the protein GM-CSF is released during rheumatoid arthritis, and that those patients are protected against Alzheimer's; that the man-made form of the protein, Leukine, has been proven safe over nearly 20 years of use; and that the mouse study has shown benefits of using the protein.

"We expect there to be no problem setting up a clinical trial," Potter said.

USF researchers get closer to a cure while studying why arthritis prevents Alzheimer's 08/22/10 [Last modified: Sunday, August 22, 2010 11:25pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times

    

Join the discussion: Click to view comments, add yours

Loading...
  1. Rays late-night bullpen shuffle: Alvarado, Pruitt down; Kolarek up

    Blogs

    The Rays shuffled their bullpen again after Tuesday's game, sending down struggling LHP Jose Alvarado along with RHP Austin Pruitt to Triple-A Durham, and turning next to LHP Adam Kolarek, who will make his major-league debut at age 28,

  2. Tampa Bay Times honored for top investigative story in Gerald Loeb annual business awards

    Business

    The Tampa Bay Times was a co-winner in the investigative category for one of the highest honors in business journalism.

    Tampa Bay Times current and former staff writers William R. Levesque, Nathaniel Lash and Anthony Cormier were honored in the investigative category for their coverage of "Allegiant Air" in the 60th Anniversary Gerald Loeb Awards for Distinguished Business and Financial Journalism. 
[JAMES BORCHUCK   |   Times

]

  3. Pasco woman gives birth to child fathered by 11 year old, deputies say

    Crime

    A Port Richey woman was arrested Tuesday, nearly three years after deputies say she gave birth to a child fathered by an 11-year-old boy.

    Marissa Mowry, 25, was arrested Tuesday on charges she sexually assaulted an 11-year-old and gave birth to his child. [Hillsborough County Sheriff's Office]
  4. For good of the Rays, Tim Beckham should embrace move to second

    The Heater

    PITTSBURGH — The acquisition of slick-fielding shortstop Adeiny Hechavarria said a lot of things, most notably that the Rays are serious about making in-season moves to bolster their chances to make the playoffs, with a reliever, or two, next on the shopping list.

    PITTSBURGH, PA - JUNE 27:  Tim Beckham #1 of the Tampa Bay Rays celebrates with teammates after scoring during the eighth inning against the Pittsburgh Pirates at PNC Park on June 27, 2017 in Pittsburgh, Pennsylvania. (Photo by Joe Sargent/Getty Images) 700011399
  5. St. Petersburg showdown: Kriseman faces Baker for first time tonight at the Rev. Louis Murphy Sr.'s church

    Local Government

    A standing-room-only crowd packed a Midtown church banquet hall Tuesday to witness the first face-off between Mayor Rick Kriseman and former mayor Rick Baker in what is a watershed mayoral contest in the city's history.

    Former Mayor Rick Baker, left, is challenging incumbent Mayor Rick Kriseman, right, to become St. Petersburg mayor.